Our InVision® platform unlocks essential genomic information from a simple blood draw to transform the care of cancer patients
Our US Medicare-reimbursed lead product InVisionFirst-Lung is already transforming the lives of advanced NSCLC patients
Our Mission
We are transforming the lives of cancer patients and their families through the power of liquid biopsy
Latest News and Events
Inivata’s Nitzan Rosenfeld to Receive 2020 Cancer Researcher Award from the European Association for Cancer Research and Pezcoller Foundation
Research Triangle Park, NC, USA and Cambridge, UK, February 27, 2020 – Inivata, a leader in liquid biopsy, is pleased to announce that ... Read More
Circulating tumor DNA analysis for patients with oncogene-addicted NSCLC with isolated central nervous system progression
Mihaela Aldea MD, PhD, Lizza Hendriks MD, PhD, Laura Mezquita MD, PhD, Cécile Jovelet PharmD, PhD, David Planchard MD, PhD, Edouard ... Read More
2020 ASCO Annual Meeting
Event expiration date display - 29 MAY - 2 JUN 2020
Location: Chicago Read More
Changing Lives
Patients are at the heart of everything we do.
Our first product is for advanced Non-Small Cell lung Cancer and our world-leading tests are already impacting patients’ lives.
This is the story of the first patient Inivata tested.
